Intellipharmaceutics International Inc. (IPCIQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Mar 19, 2025

IPCIQ Ratios and Metrics

Millions USD. Fiscal year is Dec - Nov.
Fiscal Year
CurrentFY 2022 FY 2021 FY 2020 FY 2019 FY 2018 2013 - 2017
Period Ending
Mar '25 Nov '22 Nov '21 Nov '20 Nov '19 Nov '18 2013 - 2017
Market Capitalization
--2223
Upgrade
Market Cap Growth
-13.93%-15.61%-12.65%-15.03%-91.48%
Upgrade
Enterprise Value
--3344
Upgrade
Last Close Price
0.000.070.120.130.150.33
Upgrade
PS Ratio
---1.410.651.56
Upgrade
PB Ratio
---0.28-0.31-0.610.65
Upgrade
P/TBV Ratio
-----0.65
Upgrade
P/FCF Ratio
---18.30--
Upgrade
P/OCF Ratio
---17.67--
Upgrade
EV/Sales Ratio
---2.221.082.29
Upgrade
EV/FCF Ratio
---28.77--
Upgrade
Debt / Equity Ratio
-0.17-0.22-0.23-0.33-0.520.44
Upgrade
Debt / FCF Ratio
18.42--19.52--
Upgrade
Asset Turnover
0.600.04-0.390.460.18
Upgrade
Inventory Turnover
----0.110.68
Upgrade
Quick Ratio
0.050.030.100.130.141.48
Upgrade
Current Ratio
0.060.040.110.150.201.64
Upgrade
Return on Equity (ROE)
-----3942.90%-612.54%
Upgrade
Return on Assets (ROA)
-107.39%-100.98%-95.92%-81.40%-64.13%-88.27%
Upgrade
Return on Capital (ROIC)
-----238.57%-220.06%
Upgrade
Earnings Yield
---224.66%-171.18%-356.47%-515.03%
Upgrade
FCF Yield
---107.47%5.46%-294.46%-472.42%
Upgrade
Buyback Yield / Dilution
-24.88%-12.45%-24.91%-9.18%-353.15%-53.55%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.